Exploring Viral Mimicry Combined with Epigenetics and Tumor Immunity: New Perspectives in Cancer Therapy

Overview

Journal Int J Biol Sci

Date 2025 Feb 3

PMID 39897033

Authors

Ruirui Wang

Xin Dong

Xiongjian Zhang

Jinzhuang Liao

Wei Cui

Wei Li

Affiliations

Soon will be listed here.

Abstract

Viral mimicry refers to an active antiviral response triggered by the activation of endogenous retroviruses (ERVs), usually manifested by the formation of double-stranded RNA (dsRNA) and activation of the cellular interferon response, which activates the immune system and produces anti-tumor effects. Epigenetic studies have shown that epigenetic modifications (e.g. DNA methylation, histone modifications, etc.) play a crucial role in tumorigenesis, progression, and treatment resistance. Particularly, alterations in DNA methylation may be closely associated with the suppression of ERVs expression, and treatment by demethylation may restore ERVs activity and thus strengthen the tumor immune response. Therefore, we propose that viral mimicry can induce immune responses in the tumor microenvironment by activating the expression of ERVs, and that epigenetic alterations may play a key regulatory role in this process. In this paper, we review the intersection of viral mimicry, epigenetics and tumor immunotherapy, and explore the possible interactions and synergistic effects among the three, aiming to provide a new theoretical basis and potential strategies for cancer immunotherapy.

References

Wang L, Fan Y, Zhang L, Li L, Kuang G, Luo C . Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma. FASEB J. 2018; 33(1):254-263. DOI: 10.1096/fj.201701453RR. View

Herrmann M, Hagenhofer M, Kalden J . Retroviruses and systemic lupus erythematosus. Immunol Rev. 1996; 152:145-56. DOI: 10.1111/j.1600-065x.1996.tb00914.x. View

Feng S, Marhon S, Sokolowski D, DCosta A, Soares F, Mehdipour P . Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathways. Nat Commun. 2024; 15(1):9321. PMC: 11522499. DOI: 10.1038/s41467-024-53515-8. View

Zhao H, Ning S, Nolley R, Scicinski J, Oronsky B, Knox S . The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry. Clin Epigenetics. 2017; 9:4. PMC: 5270305. DOI: 10.1186/s13148-017-0312-z. View

Zhong F, Lin Y, Zhao L, Yang C, Ye Y, Shen Z . Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics. Br J Cancer. 2023; 129(1):24-37. PMC: 10307880. DOI: 10.1038/s41416-023-02292-0. View

Niinuma T, Kitajima H, Yamamoto E, Maruyama R, Aoki H, Harada T . An Integrated Epigenome and Transcriptome Analysis to Clarify the Effect of Epigenetic Inhibitors on GIST. Anticancer Res. 2021; 41(6):2817-2828. DOI: 10.21873/anticanres.15062. View

Cortesi A, Gandolfi F, Arco F, Di Chiaro P, Valli E, Polletti S . Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer. Sci Adv. 2024; 10(13):eadk5386. PMC: 10971493. DOI: 10.1126/sciadv.adk5386. View

Rezaei S, Hayward J, Norden S, Pedersen J, Mills J, Hearps A . HERV-K Gag RNA and Protein Levels Are Elevated in Malignant Regions of the Prostate in Males with Prostate Cancer. Viruses. 2021; 13(3). PMC: 7999808. DOI: 10.3390/v13030449. View

Feng J, Zhang Y, She X, Sun Y, Fan L, Ren X . Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1α stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment. Oncogene. 2018; 38(1):103-119. PMC: 6318269. DOI: 10.1038/s41388-018-0423-9. View

10.

Wagner R, Smith J, Cooperman B, Nishikura K . A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. Proc Natl Acad Sci U S A. 1989; 86(8):2647-51. PMC: 286974. DOI: 10.1073/pnas.86.8.2647. View

11.

Chen Z, Yang X, Chen Z, Li M, Wang W, Yang R . A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy. BMC Med. 2023; 21(1):402. PMC: 10601128. DOI: 10.1186/s12916-023-03094-0. View

12.

Benmelech S, Le T, McKay M, Nam J, Subramaniam K, Tellez D . Biophysical and biochemical aspects of immune cell-tumor microenvironment interactions. APL Bioeng. 2024; 8(2):021502. PMC: 10990568. DOI: 10.1063/5.0195244. View

13.

Woyach J, Kloos R, Ringel M, Arbogast D, Collamore M, Zwiebel J . Lack of therapeutic effect of the histone deacetylase inhibitor vorinostat in patients with metastatic radioiodine-refractory thyroid carcinoma. J Clin Endocrinol Metab. 2008; 94(1):164-70. PMC: 2630867. DOI: 10.1210/jc.2008-1631. View

14.

Deblois G, Madani Tonekaboni S, Grillo G, Martinez C, Kao Y, Tai F . Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer. Cancer Discov. 2020; 10(9):1312-1329. DOI: 10.1158/2159-8290.CD-19-1493. View

15.

Gatti-Mays M, Gameiro S, Ozawa Y, Knudson K, Hicks K, Palena C . Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer. Front Oncol. 2021; 10:581801. PMC: 7977003. DOI: 10.3389/fonc.2020.581801. View

16.

Oki Y, Kelly K, Flinn I, Patel M, Gharavi R, Ma A . CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial. Haematologica. 2017; 102(11):1923-1930. PMC: 5664396. DOI: 10.3324/haematol.2017.172882. View

17.

Huang W, Zhu Q, Shi Z, Tu Y, Li Q, Zheng W . Dual inhibitors of DNMT and HDAC induce viral mimicry to induce antitumour immunity in breast cancer. Cell Death Discov. 2024; 10(1):143. PMC: 10943227. DOI: 10.1038/s41420-024-01895-7. View

18.

Peng B, Reeves K, Lee S, Chung T, Hui H, Leung A . Physical, psychological, and behavioral problems among children and adolescents in countries with different economic statuses during the COVID-19 pandemic: a systematic review and meta-analysis. Front Pediatr. 2023; 11:1181186. PMC: 10277820. DOI: 10.3389/fped.2023.1181186. View

19.

Guo Q, Qian Z . Macrophage based drug delivery: Key challenges and strategies. Bioact Mater. 2024; 38:55-72. PMC: 11061709. DOI: 10.1016/j.bioactmat.2024.04.004. View

20.

Liang Y, Wang L, Ma P, Ju D, Zhao M, Shi Y . Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitors. Front Immunol. 2023; 14:1308264. PMC: 10704038. DOI: 10.3389/fimmu.2023.1308264. View